, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Marta Crispens
Faculty Member
Last active: 3/10/2014

  1. Endometrial and ovarian cancer in lynch syndrome. Crispens MA (2012) Clin Colon Rectal Surg 25(2): 97-102
    › Primary publication · 23730224 (PubMed) · PMC3423887 (PubMed Central)
  2. A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gold MA, Brady WE, Lankes HA, Rose PG, Kelley JL, De Geest K, Crispens MA, Resnick KE, Howell SB (2012) Gynecol Oncol 125(3): 635-9
    › Primary publication · 22446624 (PubMed) · PMC4370623 (PubMed Central)
  3. An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma. Khabele D, Fadare O, Liu AY, Wilson AJ, Wass E, Osteen K, Crispens MA (2012) Int J Clin Exp Pathol 5(1): 37-45
    › Primary publication · 22295145 (PubMed) · PMC3267484 (PubMed Central)
  4. Epithelial ovarian cancer. Morgan RJ, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray HJ, Grigsby PW, Hakam A, Havrilesky LJ, Johnston C, Lele S, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Schilder RJ, Schink JC, Teng N, Werner TL, National Comprehensive Cancer Network (2011) J Natl Compr Canc Netw 9(1): 82-113
    › Primary publication · 21233246 (PubMed)
  5. Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Herington JL, Crispens MA, Carvalho-Macedo AC, Camargos AF, Lebovic DI, Bruner-Tran KL, Osteen KG (2011) Fertil Steril 95(4): 1295-301.e1
    › Primary publication · 20934690 (PubMed) · PMC3038191 (PubMed Central)
  6. Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes. Bruner-Tran KL, Carvalho-Macedo AC, Duleba AJ, Crispens MA, Osteen KG (2010) Fertil Steril 93(8): 2519-24
    › Primary publication · 19608172 (PubMed) · PMC2873129 (PubMed Central)
  7. Cervical cancer. Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA, National Comprehensive Cancer Networks (2010) J Natl Compr Canc Netw 8(12): 1388-416
    › Primary publication · 21147903 (PubMed)
  8. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W, Teng N (2009) J Natl Compr Canc Netw 7(5): 498-531
    › Primary publication · 19460278 (PubMed)
  9. Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study. McMeekin DS, Lisyanskaya A, Crispens M, Oza AM, Braly P, Doering D, Bayever E, Michiels B, Markman M (2009) Gynecol Oncol 114(2): 288-92
    › Primary publication · 19476988 (PubMed)
  10. Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography. Fleischer AC, Lyshchik A, Jones HW, Crispens MA, Andreotti RF, Williams PK, Fishman DA (2009) J Ultrasound Med 28(10): 1273-80
    › Primary publication · 19778872 (PubMed)